Patents by Inventor Tim Wintermantel

Tim Wintermantel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150080438
    Abstract: The invention relates to selective oestrogen receptor modulators (SERMs) and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of bleeding disorders, osteoporosis, endometriosis, myomata, hormone-dependent tumours, for hormone replacement therapy and for contraception.
    Type: Application
    Filed: December 4, 2012
    Publication date: March 19, 2015
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Tim Wintermantel, Carsten Moeller, Ulrich Bothe, Reinhard Nubbemeyer, Ludwig Zorn, Antonius Ter Laak, Rolf Bohlmann, Lars Wortmann
  • Publication number: 20130252890
    Abstract: The invention relates to selective oestrogen receptor modulators (SERM) and methods of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular of bleeding disorders, osteoporosis, endometriosis, myomata, hormone-dependent tumours, for hormone replacement therapy and for contraception.
    Type: Application
    Filed: June 21, 2011
    Publication date: September 26, 2013
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Tim Wintermantel, Carsten Möller, Ulrich Bothe, Reinhard Nubbemeyer, Ludwig Zorn, Dirk Kosemund, Antonius Ter Laak, Rolf Bohlmann, Lars Wortmann, Donald Bierer
  • Publication number: 20120157421
    Abstract: The invention relates to 17?-alkyl-17?-oxy-oestratrienes of the formula (I), to processes for their preparation, to the use of the 17?-alkyl-17?-oxy-oestratrienes for preparing pharmaceuticals and to pharmaceutical preparations comprising these compounds.
    Type: Application
    Filed: May 26, 2010
    Publication date: June 21, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Rolf Bohlmann, Nikolaus Heinrich, Jan Hübner, Georg Kettschau, Hermann Künzer, Philip Lienau, Michael Gerisch, Silke Köhr, Dieter Lang, Karsten Denner, Michael Sander, Jens Hoffmann, Tim Wintermantel
  • Publication number: 20110190246
    Abstract: The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen receptor such as hot flashes, vaginal dryness, osteopenia, osteoporosis, hyperlipidemia, loss of cognitive function, degenerative brain diseases, cardiovascular diseases, cerebrovascular diseases, hormone sensitive cancers and hyperplasia (in tissues including breast, endometrium, and cervix in women and prostate in men), endometriosis, uterine fibroids, osteoarthritis; and as contraceptive agents either alone or in combination with a progestogen or progestogen antagonist. The compounds of the invention are selective estrogen receptor modulators.
    Type: Application
    Filed: July 14, 2009
    Publication date: August 4, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Thorsten Blume, Dieter Heldmann, Norbert Schmees, Christiane Otto, Tim Wintermantel, Joachim Kuhnke
  • Publication number: 20100029598
    Abstract: The present invention relates to extended benzamide derivatives of the general formula I, to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP2 receptor.
    Type: Application
    Filed: July 24, 2009
    Publication date: February 4, 2010
    Applicant: Bayer Schering Pharma AG
    Inventors: Marcus Kopitz, Bernhard Lindenthal, Antonius Ter Laak, Tim Wintermantel, Olaf Peters, Gernot Langer, Nico Braeuer, Bernd Buchmann
  • Publication number: 20100029599
    Abstract: The present invention relates to indolylamide derivatives of the general formula (I), to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP2 receptor.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    Inventors: Marcus Koppitz, Antonius Ter Laak, Tim Wintermantel, Bernhard Lindenthal, Nico Bräuer, Gernot Langer, Bernd Buchmann
  • Publication number: 20090042913
    Abstract: The present invention relates to indolylalkylthienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 12, 2009
    Inventors: Nico BRAEUER, Bernd Buchmann, Marcus Koppitz, Olaf Peters, Antonius Ter Laak, Bernhard Lindenthal, Gemot Langer, Tim Wintermantel
  • Publication number: 20090042878
    Abstract: The present invention relates to thienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: July 10, 2008
    Publication date: February 12, 2009
    Inventors: Nico BRAEUER, Bernd Buchmann, Marcus Koppitz, Olaf Peters, Antonius Ter Laak, Bernhard Lindenthal, Gernot Langer, Tim Wintermantel
  • Publication number: 20090042882
    Abstract: The present invention relates to substituted acetamides of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.
    Type: Application
    Filed: June 12, 2008
    Publication date: February 12, 2009
    Inventors: Bernd BUCHMANN, Nico Braeuer, Olaf Peters, Knut Eis, Marcus Koppitz, Bernhard Lindenthal, Gernot Langer, Tim Wintermantel, Antonius Ter Laak
  • Publication number: 20090023738
    Abstract: The present invention relates to diaminopyrimidines of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.
    Type: Application
    Filed: June 19, 2008
    Publication date: January 22, 2009
    Inventors: Nico Braeuer, Bernd Buchmann, Marcus Koppitz, Antonius Ter Laak, Gernot Langer, Bernhard Lindenthal, Olaf Peters, Tim Wintermantel
  • Publication number: 20090023741
    Abstract: The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.
    Type: Application
    Filed: June 12, 2008
    Publication date: January 22, 2009
    Inventors: Bernd Buchmann, Nico Braeuer, Olaf Peters, Knut Eis, Marcus Koppitz, Bernhard Lindenthal, Gernot Langer, Tim Wintermantel, Antonius Ter Laak
  • Publication number: 20080146576
    Abstract: The present invention relates to phthalazin-1-ylpiperidin-4-ylamides of the general formula I, to processes for their preparation and to their use for producing pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: September 6, 2007
    Publication date: June 19, 2008
    Inventors: Nico Braeuer, Bernd Buchmann, Koppitz Marcus, Antonius Ter Laak, Gernot Langer, Bernard Lindenthal, Olaf Peters, Tim Wintermantel
  • Publication number: 20080125463
    Abstract: The present invention relates to (het)aryl-3-[(het)arylpiperidin-4-yl]amides, to processes for their preparation and to their use for producing pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
    Type: Application
    Filed: September 6, 2007
    Publication date: May 29, 2008
    Inventors: Nico Braeuer, Bernd Buchmann, Marcus Koppitz, Antonius Ter Laak, Gernot Langer, Bernhard Lindenthal, Olaf Peters, Tim Wintermantel
  • Publication number: 20080125435
    Abstract: The present invention relates to aryl-3-[(het)aryl-piperidin-4-yl]-thioureas, processes for the production thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are connected with the EP2 receptor.
    Type: Application
    Filed: September 6, 2007
    Publication date: May 29, 2008
    Inventors: Nico Brauer, Bernd Buchmann, Christoph Huwe, Marcus Koppitz, Antonius Ter Laak, Gernot Langer, Bernhard Lindenthal, Olaf Peters, Tim Wintermantel